Immediate Impact

43 standout
Sub-graph 1 of 22

Citing Papers

Non-invasive Scores and Serum Biomarkers for Fatty Liver in the Era of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD): A Comprehensive Review From NAFLD to MAFLD and MASLD
2024 Standout
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis
2024 Standout
2 intermediate papers

Works of Marcus Hollenbach being referenced

Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discrimination
2020

Author Peers

Author Last Decade Papers Cites
Marcus Hollenbach 146 69 77 48 387
S. W. Bender 112 36 134 34 406
R.H. Dowling 130 45 85 30 455
Milan Dastych 94 62 48 45 429
Tomoko Hagiwara 113 47 76 27 369
R Tritapepe 157 111 108 36 434
Takashi Fujisawa 250 111 60 37 434
N Darle 223 58 59 35 358
Jacek Paszkowski 130 82 23 38 346
J. A. Solís Herruzo 131 37 56 47 388
Jonas Valantinas 136 130 63 39 380

All Works

Loading papers...

Rankless by CCL
2026